M&A Deal Summary

LabCorp Acquires Myriad Autoimmune s Vectra Testing Business

On May 3, 2021, LabCorp acquired test/measurement equipment company Myriad Autoimmune s Vectra Testing Business from Myriad for 150M USD

Acquisition Highlights
  • This is LabCorp’s 5th transaction in the Test/Measurement Equipment sector.
  • This is LabCorp’s 12th largest (disclosed) transaction.
  • This is LabCorp’s 35th transaction in the United States.
  • This is LabCorp’s 3rd transaction in Utah.

M&A Deal Summary
Date 2021-05-03
Target Myriad Autoimmune s Vectra Testing Business
Sector Test/Measurement Equipment
Buyer(s) LabCorp
Sellers(s) Myriad
Deal Type Divestiture
Deal Value 150M USD

Target

Myriad Autoimmune s Vectra Testing Business

Salt Lake City, Utah, United States
Myriad Autoimmune's Vectra Testing Business is a non-invasive, blood-based test that analyzes 12 biomarkers to measure RA disease activity. It combines those measures to generate an easy-to-understand score, which indicates the severity of RA inflammation and how well current treatments are working. It also can predict potential, future joint damage. This enables the 5,000 practicing rheumatologists in the U.S. to provide targeted treatment and adjust existing treatments to better manage RA symptoms.

Search 193,724 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

LabCorp

Burlington, North Carolina, United States

website

Category Company
Founded 1994
Sector Test/Measurement Equipment
Employees70,400
Revenue 14.9B USD (2022)
DESCRIPTION
LabCorp's corporate headquarters in downtown Burlington, North Carolina.
LabCorp's corporate headquarters in downtown Burlington, North Carolina.

LabCorp of America Holdings is a provider of medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp was formed in 1994 and is based in Burlington, North Carolina.

DEAL STATS #
Overall 37 of 44
Sector (Test/Measurement Equipment) 5 of 5
Type (Divestiture) 12 of 15
State (Utah) 3 of 3
Country (United States) 35 of 42
Year (2021) 1 of 4
Size (of disclosed) 12 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-22 South Bend Medical Foundation - Diagnostic Clinical Laboratory Assets

Indiana, United States

South Bend Medical Foundation - Diagnostic Clinical Laboratory Assets provides laboratory testing services and integrates pathology services to customers in the region.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-20 Covance

Princeton, New Jersey, United States

Covance is a drug development company and a provider in nutritional analysis, is dedicated to advancing healthcare and delivering Solutions Made Real. Covance was founded in 1987 and is based in Princeton, New Jersey.

Sell -

Seller(S) 1

SELLER

Myriad

Salt Lake City, Utah, United States

website

Category Company
Founded 1991
Sector Life Science
Employees2,600
Revenue 691M USD (2021)
DESCRIPTION

Myriad is a molecular diagnostic company discovers and commercialize a transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad was founded in 1991 and is based in Salt Lake City, Utah.

DEAL STATS #
Overall 3 of 4
Sector (Test/Measurement Equipment) 1 of 1
Type (Divestiture) 3 of 4
State (Utah) 3 of 3
Country (United States) 3 of 4
Year (2021) 3 of 4
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-27 Myriad myPath Melanoma

Salt Lake City, Utah, United States

Myriad myPath Melanoma is a clinically validated GEP test designed to be used as an adjunct to histopathology when the distinction between a benign nevus and a malignant melanoma cannot be made confidently by histopathology alone.

Sell $33M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-24 Myriad RBM

Austin, Texas, United States

Myriad RBM is a multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device (TruCulture®). Myriad RBM was founded in 2002 and is based in Austin, Texas.

Sell -
Mergr

Product

Company

Legal